Veeva Systems PE Ratio 2012-2025 | VEEV
Current and historical p/e ratio for Veeva Systems (VEEV) from 2012 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Veeva Systems PE ratio as of August 14, 2025 is 57.17.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Veeva Systems PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-08-15 | 280.61 | 59.45 | |
| 2025-04-30 | 233.69 | $4.72 | 49.51 |
| 2025-01-31 | 233.26 | $4.33 | 53.87 |
| 2024-10-31 | 208.83 | $4.05 | 51.56 |
| 2024-07-31 | 191.93 | $3.75 | 51.18 |
| 2024-04-30 | 198.56 | $3.39 | 58.57 |
| 2024-01-31 | 207.41 | $3.22 | 64.41 |
| 2023-10-31 | 192.71 | $3.48 | 55.38 |
| 2023-07-31 | 204.22 | $3.32 | 61.51 |
| 2023-04-30 | 179.08 | $3.20 | 55.96 |
| 2023-01-31 | 170.55 | $3.01 | 56.66 |
| 2022-10-31 | 167.94 | $2.45 | 68.55 |
| 2022-07-31 | 223.58 | $2.43 | 92.01 |
| 2022-04-30 | 181.95 | $2.54 | 71.63 |
| 2022-01-31 | 236.54 | $2.63 | 89.94 |
| 2021-10-31 | 317.01 | $2.67 | 118.73 |
| 2021-07-31 | 332.71 | $2.62 | 126.99 |
| 2021-04-30 | 282.45 | $2.53 | 111.64 |
| 2021-01-31 | 276.44 | $2.36 | 117.14 |
| 2020-10-31 | 270.05 | $2.14 | 126.19 |
| 2020-07-31 | 264.57 | $2.06 | 128.43 |
| 2020-04-30 | 190.80 | $1.98 | 96.36 |
| 2020-01-31 | 146.61 | $1.91 | 76.76 |
| 2019-10-31 | 141.83 | $1.94 | 73.11 |
| 2019-07-31 | 165.90 | $1.83 | 90.66 |
| 2019-04-30 | 139.87 | $1.65 | 84.77 |
| 2019-01-31 | 109.06 | $1.47 | 74.19 |
| 2018-10-31 | 91.35 | $1.24 | 73.67 |
| 2018-07-31 | 75.63 | $1.05 | 72.03 |
| 2018-04-30 | 70.13 | $0.98 | 71.56 |
| 2018-01-31 | 62.86 | $0.93 | 67.59 |
| 2017-10-31 | 60.94 | $0.86 | 70.86 |
| 2017-07-31 | 63.76 | $0.79 | 80.71 |
| 2017-04-30 | 53.62 | $0.63 | 85.11 |
| 2017-01-31 | 42.33 | $0.48 | 88.19 |
| 2016-10-31 | 38.85 | $0.45 | 86.33 |
| 2016-07-31 | 37.99 | $0.37 | 102.68 |
| 2016-04-30 | 27.51 | $0.37 | 74.35 |
| 2016-01-31 | 24.10 | $0.37 | 65.14 |
| 2015-10-31 | 25.37 | $0.34 | 74.62 |
| 2015-07-31 | 26.92 | $0.34 | 79.18 |
| 2015-04-30 | 26.55 | $0.32 | 82.97 |
| 2015-01-31 | 28.76 | $0.28 | 102.71 |
| 2014-10-31 | 29.78 | $0.23 | 129.48 |
| 2014-07-31 | 23.80 | $0.21 | 113.33 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $44.935B | $2.747B |
| Veeva Systems Inc. offers cloud-based software applications and data solutions for the life sciences industry. The company's product portfolio includes Veeva CRM (customer relationship management), Veeva Vault (content and information management), Veeva Network (customer master and product data management) and Veeva data services (Veeva OpenData and Veeva KOL data). | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tempus AI (TEM) | United States | $12.393B | 0.00 |
| Doximity (DOCS) | United States | $11.901B | 52.95 |
| Hims & Hers Health (HIMS) | United States | $10.549B | 87.28 |
| IRhythm Technologies (IRTC) | United States | $5.208B | 0.00 |
| Hinge Health (HNGE) | United States | $4.462B | 0.00 |
| Privia Health (PRVA) | United States | $2.542B | 188.27 |
| Inspire Medical Systems (INSP) | United States | $2.501B | 36.77 |
| Phreesia (PHR) | United States | $1.667B | 0.00 |
| Enovis (ENOV) | United States | $1.647B | 8.71 |
| 10x Genomics (TXG) | United States | $1.630B | 0.00 |
| Omnicell (OMCL) | United States | $1.446B | 27.85 |
| Schrodinger (SDGR) | United States | $1.427B | 0.00 |
| Azenta (AZTA) | United States | $1.402B | 61.18 |
| Clover Health Investments (CLOV) | United States | $1.317B | 0.00 |
| Claritev (CTEV) | United States | $1.117B | 0.00 |
| Evolent Health (EVH) | United States | $1.035B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.665B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.509B | 0.00 |
| Veradigm (MDRX) | United States | $0.498B | 0.00 |
| Standard BioTools (LAB) | United States | $0.463B | 0.00 |
| Talkspace (TALK) | United States | $0.424B | 126.50 |
| Carlsmed (CARL) | $0.370B | 0.00 | |
| Butterfly Network (BFLY) | United States | $0.355B | 0.00 |
| TruBridge (TBRG) | United States | $0.287B | 50.40 |
| Nyxoah SA (NYXH) | Belgium | $0.232B | 0.00 |
| Outset Medical (OM) | United States | $0.229B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.222B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.206B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.190B | 0.00 |
| CapsoVision (CV) | United States | $0.186B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.134B | 0.00 |
| American Well (AMWL) | United States | $0.117B | 0.00 |
| CareCloud (CCLD) | United States | $0.108B | 4.92 |
| EUDA Health Holdings (EUDA) | Singapore | $0.097B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.093B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.069B | 0.00 |
| Pulmonx (LUNG) | United States | $0.062B | 0.00 |
| 111 (YI) | China | $0.057B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.050B | 0.00 |
| HeartBeam (BEAT) | United States | $0.038B | 0.00 |
| Zhongchao (ZCMD) | China | $0.024B | 0.00 |
| Precipio (PRPO) | United States | $0.024B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.019B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.013B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.009B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.005B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| PROFUSA (PFSA) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |